Automated Breast Ultrasound Systems Market to hit US$ 7.23 Billion and grow at a CAGR of 14% from forecast 2023 to 2033 | Data by Future Market Insights, Inc.

Growing prevalence of breast cancer and rising technological advancements in automated breast ultrasound systems are driving market growth. The automated breast ultrasound system market in Germany is primarily driven by rapid urbanization, the presence of an established healthcare infrastructure, advantageous insurance policies, rising consumer healthcare spending, and escalating need for advanced non-invasive breast imaging techniques


NEWARK, Del, June 12, 2023 (GLOBE NEWSWIRE) -- The Automated Breast Ultrasound Systems Market is estimated to secure a valuation of US$ 1.95 billion in 2023 and is predicted to reach US$ 7.23 billion by 2033. The market is anticipated to register a CAGR of 14% during the forecast period.

How do Patients Prefer the Automated Breast Ultrasound Systems?

Several benefits may influence patients to prefer automated breast ultrasound systems are:

  • Non-invasive: The automated breast ultrasound system is a non-invasive device that provides reliable, comfortable, and enhanced patient experiences. Therefore, patients prefer these systems to detect chronic diseases.
  • Increased Sensitivity: Automated breast ultrasound systems detect additional breast lesions and tissues. It seems more challenging to detect dense breast tissue with other devices. Therefore, the adoption of automated breast ultrasound systems is highly preferred by patients.
  • Additional Information: Related information about breast lesions, including shape, size, and location, is informed by automated breast ultrasound systems. It helps to aid in planning treatment with better results.
  • Quick and Efficient: Automated breast ultrasound systems perform tasks quickly, reliably, and efficiently. Compared to traditional handheld ultrasound, it takes only a few minutes to provide accurate results. Due to its convenience and consistency, patients prefer these systems.

Get your PDF Sample Report with Latest Market Information @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

These are a few of the factors on which patients are preferring automated breast ultrasound systems.

Key Takeaways:

  • The automated breast ultrasound systems market is estimated to secure a valuation of US$ 7.23 billion with a CAGR of 14% by 2033.
  • In the historical period, the market secured a valuation of US$ 1.71 billion in 2022.
  • The United States is estimated to register a maximum share in the global market by 2033.
  • Based on end users, the hospital sector will dominate the global market by capturing huge revenue by 2033.

How are Key Players Adding Value by Adopting Marketing Tactics?

The global market is highly competitive, with a number of key players globally. These players significantly drive the global market by capturing huge market revenue. The key players focus on developing innovative products by investing millions in research activities. They are focused on consumers' preferences and offer them an improved product to attract them.

They are adopting several marketing tactics to upsurge the global market, including mergers, collaborations, acquisitions, product launches, and partnerships. Key players continue to experiment with developing products with advanced and latest technologies to provide patients with better devices to detect diseases. They are marketing and promoting their brand product on social media and other online platforms to reach relevant customers.

They offer efficient, light-weighted, comfortable, and reliable products to the end users, including hospitals, laboratories, and other healthcare sectors. By adding advanced features such as artificial intelligence, they are expanding the global market revenue in the coming years.

Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-606

Recent Developments in the Global Market:

In 2020, Siemens Healthineers AG launched its new product, the automated breast ultrasound systems ACUSON S2000 ABVS. It provides a 3D image to detect dense breast tissue and lesions. The company provides this ultrasound system connected with remote services to provide seamless experiences to their patients.

Major Players in this Market are:

  • GE Healthcare
  • Hitachi Ltd.
  • SonoCine Inc
  • Philips Healthcare
  • Siemens Healthineers
  • Supersonic Imagine
  • Toshiba Corporation
  • QT Ultrasound LLC
  • Adaltis S.r.l.
  • Volpara Health Technologies
  • Delphinus Medical Technologies, Inc
  • General Electric Company
  • Hologic, Inc
  • Telemed Systems, Inc

Global Market by Categorization:

End User:

  • Hospitals
  • Diagnostic Imaging Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

For More Report Customization, connect with us @ https://www.futuremarketinsights.com/customization-available/rep-gb-606

Table of Content (ToC):
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

View the Complete ToC of this Report with figures @ https://www.futuremarketinsights.com/toc/rep-gb-606

Explore FMI’s related ongoing Coverage on Healthcare Market Domain:

Lung Cancer Surgery Market Size: The global Lung Cancer Surgery Market was valued at US$ 1.23 Billion in 2021 and is expected to reach US$ 1.98 Billion by 2029, finds Future Market Insights (FMI) in a recent market survey.

Tissue Diagnostics Market Share: The global tissue diagnostics market was valued at US$ 32.0 Billion in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022 to 2032, with a market valuation of US$ 120.2 Billion by 2032.

Lung Cancer Therapeutics Market Demand: The global lung cancer therapeutics market share is projected to reach US$ 48,725.9 Million by 2026, exhibiting a CAGR of 13.4% in the forecast period 2022 to 2032.

Mastectomy Reconstruction Implants Market Opportunity: According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at US$ 1.95 Billion in 2022 and is set to reach US$ 4.69 Billion by 2033.

Poultry Diagnostics Market Growth: The global poultry diagnostics demand is subjected to record a CAGR of 10.5%. The market revenue is likely to be valued at US$ 590 million in 2023 and exhibit a revenue growth of US$ 1.6 billion by 2033.

Advanced Cancer Pain Management Market Trends: The global advanced cancer pain management market is anticipated to attain a valuation of US$ 7,265.44 million in 2023 and is estimated to reach US$ 11,540 million by 2033, trailing a CAGR of 4.74% during the forecast period.

Chlamydia Diagnostics Market Development: The global chlamydia diagnostics market garnered a market value of US$ 1.17 Billion in 2022 and is expected to accumulate a market value of US$ 3.69 Billion by registering a CAGR of 11% in the forecast period 2023 to 2033. 

Cancer Diagnostics Market Outlook: The global cancer diagnostics market is projected to expand steadily at a CAGR of 7.1% value, during the forecast period 2022 to 2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the cancer diagnostics market is expected to reach US$ 379 Billion by 2032.

Infectious Disease Diagnostics Market Strategies: In 2022, the infectious disease diagnostics market is anticipated to be worth US$ 1.47 billion in terms of revenue. The market is projected to expand at a CAGR of 7% to reach a size of US$ 3.48 billion by 2032.

Digital Breast Tomosynthesis (DBT) Equipment Market Forecast: The global digital breast tomosynthesis (DBT) equipment market is expected to enjoy a valuation of US$ 2.3 Billion in the year 2022, and further expand at a CAGR rate of 14.1% to reach a valuation of ~US$ 8.4 Billion by the year 2032. 

About Future Market Insights (FMI):

Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com